$919M
$341 Billion
34.94% of portfolio
10,181,070
Q1 2024
Added 44.61%
$4.06B
$237 Billion
24.36% of portfolio
65,760,909
Q2 2025
Added 1.42%
$1.32B
$86.4 Billion
8.86% of portfolio
6,174,540
Q2 2025
Reduced 1.52%
$4.57B
$44.6 Billion
4.57% of portfolio
7,438,818
Q1 2025
New
$3.38B
$27.9 Billion
2.86% of portfolio
5,630,478
Q2 2025
Reduced 12.67%
$1.57B
$25 Billion
2.57% of portfolio
3,467,298
Q1 2025
Added 52.56%
-
$19.7 Billion
2.02% of portfolio
-
Q2 2025
Added 185.71%
$6.74B
$18.4 Billion
1.89% of portfolio
649,493
Q1 2025
New
$18.4B
$17.6 Billion
1.81% of portfolio
1,050,649
Q2 2025
New
$0
$13.8 Billion
1.41% of portfolio
1,172,523
Q2 2025
New
$10.3B
$12.9 Billion
1.32% of portfolio
416,533
Q2 2025
New
$0
$12.7 Billion
1.31% of portfolio
21,263,656
Q2 2025
Added 25.22%
$1.64B
$10.4 Billion
1.06% of portfolio
342,885
Q2 2025
Added 37.53%
$3.33B
$10.2 Billion
1.04% of portfolio
1,146,022
Q2 2025
Reduced 76.72%
$2.07B
$9.82 Billion
1.01% of portfolio
269,133
Q2 2025
Reduced 2.71%
$3.86B
$9.71 Billion
1.0% of portfolio
1,321,068
Q2 2025
New
$351M
$7.63 Billion
0.78% of portfolio
6,011,627
Q2 2025
Added 67.17%
$668M
$7.39 Billion
0.76% of portfolio
529,798
Q2 2025
Added 14.59%
$715M
$6.92 Billion
0.71% of portfolio
360,433
Q2 2025
Added 2.09%
Mineralys Therapeutics Inc
-
$6.04 Billion
0.62% of portfolio
-
Q2 2025
Added 11.8%
$685M
$5.78 Billion
0.59% of portfolio
2,640,384
Q2 2025
Added 1.84%
$202M
$5.55 Billion
0.57% of portfolio
1,676,451
Q2 2025
Added 25.51%
$961M
$4.92 Billion
0.5% of portfolio
530,135
Q2 2025
Added 20.65%
$725M
$2.93 Billion
0.3% of portfolio
154,278
Q2 2025
Added 92.32%
$3.02B
$1.83 Billion
0.19% of portfolio
128,054
Q2 2025
New
-
$1.49 Billion
0.15% of portfolio
-
Q2 2025
Reduced 48.12%
$1.55B
$1.07 Billion
0.11% of portfolio
85,700
Q2 2025
New
-
$946 Million
0.1% of portfolio
-
Q1 2025
Added 85.19%
$109M
$977 Million
0.1% of portfolio
775,055
Q2 2025
Reduced 1.48%
$1.02B
$774 Million
0.08% of portfolio
84,637
Q2 2025
New
$666M
$746 Million
0.08% of portfolio
87,994
Q2 2025
Reduced 14.76%
$70.1M
$824 Million
0.08% of portfolio
460,303
Q2 2025
Added 86.74%
Adverum Biotechnologies Inc
-
$771 Million
0.08% of portfolio
-
Q2 2025
Reduced 2.59%
$167M
$387 Million
0.04% of portfolio
51,202
Q4 2024
Reduced 61.58%
$420M
$261 Million
0.03% of portfolio
26,578
Q2 2025
Added 7.26%
$156M
$270 Million
0.03% of portfolio
25,689
Q2 2025
Added 154.85%
$943M
$265 Million
0.03% of portfolio
8,683
Q2 2025
Added 6.76%
$0
$249 Million
0.03% of portfolio
30,686
Q2 2025
New
$1.97B
$204 Million
0.02% of portfolio
5,600
Q2 2025
New
$451M
$226 Million
0.02% of portfolio
34,843
Q2 2025
Added 9.94%
$489M
$184 Million
0.02% of portfolio
34,270
Q1 2025
Added 8.93%
$748M
$213 Million
0.02% of portfolio
15,940
Q2 2025
Reduced 9.64%
$99M
$233 Million
0.02% of portfolio
32,458
Q2 2025
Added 19.01%
$132M
$218 Million
0.02% of portfolio
57,128
Q2 2025
New
$241M
$219 Million
0.02% of portfolio
49,122
Q2 2025
Added 4.24%
$1.88B
$214 Million
0.02% of portfolio
13,571
Q2 2025
Added 11.05%
$350M
$229 Million
0.02% of portfolio
27,846
Q2 2025
Added 7.74%
$504M
$187 Million
0.02% of portfolio
95,642
Q2 2025
Added 109.55%
-
$212 Million
0.02% of portfolio
-
Q2 2025
New
$160M
$108 Million
0.01% of portfolio
37,518
Q1 2025
Added 16.12%